Edition:
United Kingdom

People: Catalyst Biosciences Inc (CBIO.OQ)

CBIO.OQ on NASDAQ Stock Exchange Capital Market

8.38USD
15 Jul 2019
Change (% chg)

$-0.12 (-1.41%)
Prev Close
$8.50
Open
$8.46
Day's High
$8.46
Day's Low
$8.29
Volume
25,768
Avg. Vol
56,641
52-wk High
$14.35
52-wk Low
$6.20

Himawan, Jeffrey 

Mr. Jeffrey Himawan is Director of the company. He is currently a managing director at Essex Woodlands Health Ventures, a healthcare focused venture capital firm, where he previously served as a venture partner from 2001 to 2004 and as an adjunct partner from 1999 to 2001. He has over 20 years of experience as a scientist, entrepreneur and venture capitalist. Dr. Himawan was a co-founder and managing director of Seed-One Ventures, LLC, a venture capital firm that specializes in the initial formation, financing and early operational development of technology-based companies, from 1996 to 2001. From 1983 to 1996, Dr. Himawan was a scientist in both academic and industrial settings. Dr. Himawan has been a member of the board of directors of Catalyst since December 2008. He currently serves as a director of MediciNova, Horizon Pharma, Light Sciences Oncology, OMT Therapeutics and Symphogen. He has previously served as a director of Iomai and Complete Genomics. Dr. Himawan received his B.S. from Massachusetts Institute of Technology and his Ph.D. from Harvard University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --